| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 69238-1657-4 | 69238-1657 | HUMAN PRESCRIPTION DRUG | Tavaborole | Tavaborole | SOLUTION | TOPICAL | 20201128 | N/A | ANDA | ANDA212256 | Amneal Pharmaceuticals NY LLC | TAVABOROLE | 43.5 mg/mL | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (69238-1657-4) / 4 mL in 1 BOTTLE, WITH APPLICATOR |
| 69238-1657-6 | 69238-1657 | HUMAN PRESCRIPTION DRUG | Tavaborole | Tavaborole | SOLUTION | TOPICAL | 20201128 | N/A | ANDA | ANDA212256 | Amneal Pharmaceuticals NY LLC | TAVABOROLE | 43.5 mg/mL | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (69238-1657-6) / 10 mL in 1 BOTTLE, WITH APPLICATOR |